Cincinnati Business Courier: Nation's rising star in cancer care
A UC surgeon named '40 under 40' by national organizations
University of Cincinnati Cancer Center surgeon Sameer Patel, MD, an assistant professor in the department of surgery, division of surgical oncology, and a UC Health surgical oncologist, was named one of the country’s top “40 Under 40 in Cancer,” an award that identifies and recognizes “rising stars and emerging leaders” in the field of oncology under 40 years old.
The award, in its third year, is sponsored by the Lynx Group, Upstream Partners, Swim Across America and the National Community Oncology Dispensing Association Inc. Awardees were selected by a panel of reviewers.
“I am humbled to be considered a member [along] with so many inspiring people,” Patel said. “We hope to continue to make strides to fight cancer.”
Read the full Cincinnati Business Courier story. [This link may require a password.]
Featured photo of Sameer Patel courtesy of UC Health.
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.